Multi-modal molecular determinants of clinically relevant osteoporosis subtypes
-
Published:2024-03-12
Issue:1
Volume:10
Page:
-
ISSN:2056-5968
-
Container-title:Cell Discovery
-
language:en
-
Short-container-title:Cell Discov
Author:
Yuan ChunchunORCID, Yu Xiang-Tian, Wang Jing, Shu Bing, Wang Xiao-Yun, Huang Chen, Lv Xia, Peng Qian-Qian, Qi Wen-Hao, Zhang Jing, Zheng Yan, Wang Si-JiaORCID, Liang Qian-Qian, Shi Qi, Li Ting, Huang He, Mei Zhen-Dong, Zhang Hai-Tao, Xu Hong-Bin, Cui Jiarui, Wang Hongyu, Zhang Hong, Shi Bin-Hao, Sun Pan, Zhang Hui, Ma Zhao-Long, Feng Yuan, Chen LuonanORCID, Zeng TaoORCID, Tang De-Zhi, Wang Yong-Jun
Abstract
AbstractDue to a rapidly aging global population, osteoporosis and the associated risk of bone fractures have become a wide-spread public health problem. However, osteoporosis is very heterogeneous, and the existing standard diagnostic measure is not sufficient to accurately identify all patients at risk of osteoporotic fractures and to guide therapy. Here, we constructed the first prospective multi-omics atlas of the largest osteoporosis cohort to date (longitudinal data from 366 participants at three time points), and also implemented an explainable data-intensive analysis framework (DLSF: Deep Latent Space Fusion) for an omnigenic model based on a multi-modal approach that can capture the multi-modal molecular signatures (M3S) as explicit functional representations of hidden genotypes. Accordingly, through DLSF, we identified two subtypes of the osteoporosis population in Chinese individuals with corresponding molecular phenotypes, i.e., clinical intervention relevant subtypes (CISs), in which bone mineral density benefits response to calcium supplements in 2-year follow-up samples. Many snpGenes associated with these molecular phenotypes reveal diverse candidate biological mechanisms underlying osteoporosis, with xQTL preferences of osteoporosis and its subtypes indicating an omnigenic effect on different biological domains. Finally, these two subtypes were found to have different relevance to prior fracture and different fracture risk according to 4-year follow-up data. Thus, in clinical application, M3S could help us further develop improved diagnostic and treatment strategies for osteoporosis and identify a new composite index for fracture prediction, which were remarkably validated in an independent cohort (166 participants).
Funder
he National Key Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Reference107 articles.
1. Peck, W. A. et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J. Med. 94, 646–650 (1993). 2. Schonau, J., Wester, A., Schattenberg, J. M. & Hagstrom, H. Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: a population-based cohort study. J. Int. Med. 294, 164–177 (2023). 3. Wang, O. et al. A survey of outcomes and management of patients post fragility fractures in China. Osteoporos. Int. 26, 2631–2640 (2015). 4. Compston, J. E., McClung, M. R. & Leslie, W. D. Osteoporosis. Lancet 393, 364–376 (2019). 5. Sarafrazi, N., Wambogo, E. A. & Shepherd, J. A. Osteoporosis or low bone mass in older adults: United States, 2017-2018. NCHS Data Brief. 1–8 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|